Journey Medical Corp Insider Trading

DERM

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Mar 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Mar 2024

Mar 25, 2024

Get an email when DERM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 2, 2025	Claude Maraoui President & CEO	SoldNo plan	4,834	$6.84	33K	0.2%	Form 4
May 2, 2025	Joseph Benesch CFO	SoldNo plan	2,409	$6.84	16K	1.2%	Form 4
May 2, 2025	Ramsey Alloush COO	SoldNo plan	2,857	$6.84	20K	0.6%	Form 4
Mar 11, 2025	Claude Maraoui President & CEO	SoldNo plan	49,271	$5.01	247K	2.4%	Form 4
Mar 6, 2025 – Mar 7, 2025	Claude Maraoui President & CEO	SoldNo plan 2 parts	40,456	$5.03 average	203K	1.9%	Form 4
Mar 3, 2025 – Mar 5, 2025	Claude Maraoui President & CEO	SoldNo plan 3 parts	70,556	$5.11 average	361K	3.3%	Form 4
Feb 21, 2025	Joseph Benesch CFO	SoldNo plan	1,365	$5.19	7K	2.9%	Form 4

May 2, 2025No plan
Claude Maraoui
President & CEO · sold 4,834 at $6.84
33K
0.2% of stake
May 2, 2025No plan
Joseph Benesch
CFO · sold 2,409 at $6.84
16K
1.2% of stake
May 2, 2025No plan
Ramsey Alloush
COO · sold 2,857 at $6.84
20K
0.6% of stake
Mar 11, 2025No plan
Claude Maraoui
President & CEO · sold 49,271 at $5.01
247K
2.4% of stake
Mar 6, 2025 – Mar 7, 2025No plan
Claude Maraoui
President & CEO · sold 40,456 at avg $5.03
203K
1.9% of stake
Mar 3, 2025 – Mar 5, 2025No plan
Claude Maraoui
President & CEO · sold 70,556 at avg $5.11
361K
3.3% of stake
Feb 21, 2025No plan
Joseph Benesch
CFO · sold 1,365 at $5.19
7K
2.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DERM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with DERM

CompareIntrinsic value

RMTIRockwell Medical, Inc.

$8.05-0.49%37

ENTAEnanta Pharmaceuticals Inc.

$10.65+2.70%25

LXRXLexicon Pharmaceuticals, Inc.

$1.48+1.37%40

FBIOFortress Biotech Inc.

$1.97+1.55%59

VRDNViridian Therapeutics Inc.

$29.06+15.53%40

ASMBAssembly Biosciences Inc.

$19.87-0.25%19

KURAKura Oncology Inc.

$7.61-22.98%10

XLOXilio Therapeutics, Inc.

$8.71+0.35%40

Held by ETFs

DERM is in 2 US ETFs. The largest of them, with DERM's weight in each:

Spot a number that looks wrong? Check it in DERM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DERM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.